Walgreens Apricot Scrub Acne Treatment

Description

The product is identified by the SPL Code 34089-3 and is associated with the reference W90491A. It is represented in a media type of image/jpeg, with the corresponding image file named W90491A.jpg.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

The affected area should be covered with a thin layer of the medication and rinsed thoroughly. Initial application should be limited to once daily to minimize the risk of excessive skin drying. Based on the patient's response, the frequency may be gradually increased to two or three times daily, as needed or as directed by a healthcare professional.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the application frequency to once daily or every other day. Careful monitoring of the skin's response is advised to ensure optimal treatment outcomes while minimizing adverse effects.

Contraindications

Use of this product is contraindicated in patients with a history of eye contact. In the event of contact with the eyes, it is imperative to flush thoroughly with water to mitigate potential irritation or injury. No other contraindications have been identified.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to adhere strictly to this guideline to prevent unintended systemic exposure.

Skin irritation and dryness may be exacerbated when this product is used concurrently with other topical acne medications. It is recommended that only one topical acne treatment be utilized at a time to minimize the risk of irritation. Patients should be monitored for signs of skin irritation and dryness, and appropriate adjustments to their treatment regimen should be made as necessary.

Contact with the eyes should be strictly avoided. In the event of accidental contact, patients should be instructed to flush the affected area thoroughly with water to mitigate potential adverse effects.

In cases of ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay. Prompt action is critical to ensure patient safety.

Patients should be advised to discontinue use and consult their healthcare provider if they experience any concerning symptoms, although no specific instructions for cessation have been provided in the available text. Regular follow-up may be beneficial to assess the patient's response to treatment and to address any emerging concerns.

Side Effects

For external use only. No specific adverse reactions or side effects have been reported in clinical trials or postmarketing experiences. Patients should be advised to use the product as directed and to consult a healthcare professional if any unexpected reactions occur.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Walgreens Apricot Scrub Acne Treatment (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this medication. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For topical application, it is recommended to initiate treatment with one application daily. Depending on the patient's response and as directed by a healthcare professional, the frequency may be gradually increased to two or three times daily. Care should be taken to observe for excessive drying of the skin; if bothersome dryness or peeling occurs, the application frequency should be reduced to once a day or every other day.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The product has not been specifically studied in pregnant patients, and the prescribing information does not provide explicit warnings or precautions regarding its use during pregnancy. There are no stated safety concerns, contraindications, or dosage modifications for pregnant individuals. Additionally, no special precautions regarding the use of this product during pregnancy are mentioned. Healthcare professionals should consider the absence of data when advising women of childbearing potential and pregnant patients regarding the use of this product.

Lactation

There are no specific statements regarding the use of this medication in nursing mothers or lactation. Additionally, there is no available data on the excretion of this medication in breast milk or its effects on breastfed infants. Healthcare professionals should consider the absence of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, ensuring adequate ventilation, and monitoring vital signs.

If available, the use of antidotes or specific treatments should be considered based on the clinical scenario and the substance involved. Consultation with a poison control center or a medical toxicologist may provide additional guidance on the management of overdose cases.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed.

It is important to inform patients that the use of this medication in conjunction with other topical acne treatments may increase the likelihood of skin irritation and dryness. Therefore, if patients experience any irritation, they should be instructed to use only one topical acne medication at a time to minimize adverse effects.

Patients should also be cautioned to avoid contact with the eyes. In the event of accidental contact, they should be directed to flush the eyes thoroughly with water to reduce the risk of irritation or injury.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. Proper handling should be observed to ensure optimal conditions are met throughout the storage period.

Additional Clinical Information

The medication is administered topically, requiring patients to cover the entire affected area with a thin layer and rinse thoroughly one to three times daily. To minimize the risk of excessive skin drying, it is recommended to start with one application daily, gradually increasing to two or three times daily as needed or directed by a clinician. Should patients experience bothersome dryness or peeling, they should reduce the application frequency to once a day or every other day.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Walgreens Apricot Scrub Acne Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)